[go: up one dir, main page]

BRPI0907317A2 - composição farmacêutica e método para fabricar uma composição farmacêutica tópica em gel, espuma e em spray - Google Patents

composição farmacêutica e método para fabricar uma composição farmacêutica tópica em gel, espuma e em spray Download PDF

Info

Publication number
BRPI0907317A2
BRPI0907317A2 BRPI0907317A BRPI0907317A BRPI0907317A2 BR PI0907317 A2 BRPI0907317 A2 BR PI0907317A2 BR PI0907317 A BRPI0907317 A BR PI0907317A BR PI0907317 A BRPI0907317 A BR PI0907317A BR PI0907317 A2 BRPI0907317 A2 BR PI0907317A2
Authority
BR
Brazil
Prior art keywords
pharmaceutical composition
urine
foam
gel
making
Prior art date
Application number
BRPI0907317A
Other languages
English (en)
Inventor
Lulla Amar
Malhotra Geena
Original Assignee
Cipla Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cipla Ltd filed Critical Cipla Ltd
Publication of BRPI0907317A2 publication Critical patent/BRPI0907317A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4412—Non condensed pyridines; Hydrogenated derivatives thereof having oxo groups directly attached to the heterocyclic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A61K9/122—Foams; Dry foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7015—Drug-containing film-forming compositions, e.g. spray-on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)

Abstract

"artigos absorventes capazes de indicar a presença de urina" de acordo com uma modalidade da presente invenção é descrito um método para detectar urina. o método inclui contatar urina com um substrato. o substrato inclui fibras celulósicas carregadas tendo uma composição de mudança de cor imobilizada sobre o mesmo, a composição de mudança de cor incluindo um indicador de ph, um ajustador de ph, e um agente de capacidade de umedecimento, em que o indicador de ph é configurado para mudar a cor quando contatado com urina. a presença de urina é determinada com base em uma mudança na cor do indicador de ph.
BRPI0907317A 2008-04-16 2009-04-16 composição farmacêutica e método para fabricar uma composição farmacêutica tópica em gel, espuma e em spray BRPI0907317A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN862MU2008 2008-04-16
PCT/GB2009/000975 WO2009127825A1 (en) 2008-04-16 2009-04-16 Topical combinations comprising an antimycotic agent and an antiviral agent

Publications (1)

Publication Number Publication Date
BRPI0907317A2 true BRPI0907317A2 (pt) 2019-08-27

Family

ID=40901978

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0907317A BRPI0907317A2 (pt) 2008-04-16 2009-04-16 composição farmacêutica e método para fabricar uma composição farmacêutica tópica em gel, espuma e em spray

Country Status (12)

Country Link
US (1) US20110104262A1 (pt)
EP (1) EP2282777A1 (pt)
JP (1) JP2011518140A (pt)
KR (1) KR20110003534A (pt)
CN (1) CN102006889A (pt)
AU (1) AU2009237478A1 (pt)
BR (1) BRPI0907317A2 (pt)
CA (1) CA2721457A1 (pt)
MX (1) MX2010011244A (pt)
RU (1) RU2010146482A (pt)
WO (1) WO2009127825A1 (pt)
ZA (1) ZA201007309B (pt)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2391208A4 (en) * 2009-01-30 2012-09-12 Yissum Res Dev Co COMPOSITIONS FOR THE TREATMENT OF NAILS AND SKIN
US20130028959A1 (en) * 2009-12-16 2013-01-31 Massachusetts Institute Of Technology Liposomes for Preventing the Spread of HIV
AU2011264952B2 (en) * 2010-06-11 2014-08-14 Quarraisha Abdool Karim Topical antiviral formulations for prevention of transmission of HSV-2
CN102525883B (zh) * 2010-12-09 2013-05-08 丽珠集团丽珠制药厂 一种伏立康唑栓剂及其制备方法和用途
CN102505180A (zh) * 2011-09-16 2012-06-20 彭可扬 一种用于防治室内微生物污染的负载伊曲康唑-溶菌酶电纺纤维膜
KR101154328B1 (ko) * 2011-10-27 2012-06-14 주식회사 에코산업 수용성 나노 고분자를 이용한 무좀치료용 하이드로겔 패치의 제조방법
HK1208809A1 (en) * 2012-06-13 2016-03-18 伊沃菲姆股份有限公司 Compositions and methods for enhancing the efficacy of contraceptive microbicides
WO2014041378A2 (en) * 2012-09-14 2014-03-20 Cipla Limited Topical pharmaceutical composition
KR101388855B1 (ko) * 2013-02-08 2014-04-24 경북대학교 산학협력단 이미다졸 또는 피리딘이 결합된 콜레스탄 유도체 또는 이의 약제학적으로 허용 가능한 염을 유효성분으로 포함하는 항생제 조성물
KR102407408B1 (ko) 2013-12-19 2022-06-10 에보펨 인코포레이티드 알긴산계 항균성 화합물을 사용하는 염증 및 질병을 억제하기 위한 조성물 및 방법
CN104971045A (zh) 2014-04-11 2015-10-14 上海宣泰医药科技有限公司 泊沙康唑药物组合物及其制备方法和药物制剂
WO2017161136A1 (en) * 2016-03-18 2017-09-21 Oak Crest Institute Of Science Acid salts for vaginal drug delivery
EP3522879A4 (en) 2016-10-04 2020-06-03 Evofem, Inc. Method of treatment and prevention of bacterial vaginosis
CN108619495A (zh) * 2018-04-24 2018-10-09 金寨县鑫和新能源科技有限公司 一种辅助治疗盆腔积液的保健品的组合物
CN112891323B (zh) * 2020-01-22 2023-08-18 首都医科大学附属北京地坛医院 一种抗hiv外用消毒剂及其制备方法
IT202000017125A1 (it) * 2020-07-15 2022-01-15 Univ Degli Studi Padova Composto e composizione farmaceutica per l’uso nel metodo di trattamento delle infezioni da citomegalovirus umano
CN115400086B (zh) * 2022-10-08 2023-08-22 山东新时代药业有限公司 聚甲酚磺醛脂质体、制剂及其制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4108309A (en) * 1976-10-15 1978-08-22 All One God Faith, Inc. Contraceptive containing device
US4360013A (en) * 1980-04-21 1982-11-23 Minnesota Mining And Manufacturing Company Polymeric acid contraceptive devices
US4589880A (en) * 1983-07-14 1986-05-20 Southern Research Institute Disposable spermicide-releasing diaphragm
US5292516A (en) * 1990-05-01 1994-03-08 Mediventures, Inc. Body cavity drug delivery with thermoreversible gels containing polyoxyalkylene copolymers
WO1995012602A1 (en) * 1993-11-05 1995-05-11 Meiji Milk Products Co., Ltd. Antibacterial, antifungal and antiviral agent
US20050276836A1 (en) * 1997-06-11 2005-12-15 Michelle Wilson Coated vaginal devices for vaginal delivery of therapeutically effective and/or health-promoting agents
JP2002536319A (ja) * 1999-02-05 2002-10-29 シプラ・リミテッド 局所用スプレー
AU2003224767A1 (en) * 2002-03-26 2003-10-13 Eastern Virginia Medical School Suramin and derivatives thereof as topical microbicide and contraceptive
US20050037033A1 (en) * 2003-05-23 2005-02-17 Program For Appropriate Technology In Health Microbicidal compositions and methods and use
US20050196418A1 (en) * 2004-03-04 2005-09-08 Yu Ruey J. Bioavailability and improved delivery of alkaline pharmaceutical drugs

Also Published As

Publication number Publication date
WO2009127825A1 (en) 2009-10-22
EP2282777A1 (en) 2011-02-16
JP2011518140A (ja) 2011-06-23
CA2721457A1 (en) 2009-10-22
ZA201007309B (en) 2011-06-29
MX2010011244A (es) 2010-11-09
CN102006889A (zh) 2011-04-06
US20110104262A1 (en) 2011-05-05
RU2010146482A (ru) 2012-05-27
KR20110003534A (ko) 2011-01-12
AU2009237478A1 (en) 2009-10-22

Similar Documents

Publication Publication Date Title
BRPI0907317A2 (pt) composição farmacêutica e método para fabricar uma composição farmacêutica tópica em gel, espuma e em spray
BRPI0907303A2 (pt) "artigos absorventes capazes de indicar a presença de urina"
BRPI0917734B8 (pt) artigo absorvente, e, tampão
BR112012026835A2 (pt) não-tecido que tem revestimento hidrofílico durável
BRPI0811198A8 (pt) Fosfatase alcalina direcionada a osso, kits e métodos de seu uso
BR112012015118A2 (pt) núcleo absorvente com padrão de adesivo
BRPI0601479A (pt) bandagem adesiva
BR112014005437A2 (pt) indicador de umidade com colorações variada
BRPI0612967B8 (pt) método para a determinação in vitro da atividade de trombina em uma amostra biológica e kit
BRPI0914481B8 (pt) artigo absorvente capaz de indicar a presença ou a ausência de urina, assim como vazamento iminente de urina
BR112013000114A2 (pt) composição de limpeza e processo para limpeza de um substrato
CO6150115A2 (es) Metodo para predecir un evento incontinente
AR064301A1 (es) Absorbente de fosfato basado en hierro (iii)
BRPI0606380A2 (pt) tratamento de substratos para melhorar a aderência de tinta aos substratos
BRPI0703317A (pt) composição de toner
BRPI0703525A (pt) composições de toner
BR112013002160A2 (pt) sistema para a distribuição de uma tira de produto absorvente enrolada na forma de um rolo compatível
BRPI0702328A (pt) artigo absorvente conformável
BRPI1011564A8 (pt) Fio de material de sutura cirúrgica, kit cirúrgico e método para produzir fio
BRPI0705487A (pt) tampões para abertura para a distribuição de agentes ativos
BR112015003439A2 (pt) composição e material que mudam de cor
BRPI1005994A2 (pt) partícula que compreende um amido de carboxialquila que é permeado com um gás ácido, composição absorvente, uso da partícula, processo para a fabricação de um polímero superabsorvente e processo para ajustar o ph de um extrudato de amido alcalino"
BRPI0702618A (pt) artigo absorvente conformável
BRPI0909797A2 (pt) Composição oftálmica
BRPI0820888B8 (pt) Copolímero de metacrilato de aminoalquila e, seu uso e seu método de produção, e formulação farmacêutica

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B04C Request for examination: application reinstated [chapter 4.3 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 8A, 9A E 10A ANUIDADES.

B25G Requested change of headquarter approved

Owner name: CIPLA LIMITED (IN)

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2541 DE 17-09-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.

B350 Update of information on the portal [chapter 15.35 patent gazette]